Furthermore, a soluble recombinant LAG-3–Ig fusion protein, i.e., IMP321, has been studied as an immunological adjuvant for vaccination against cancer, and it was able to promote cytokine production of NK cells in a healthy individual and cancer patients in ex vivo culture conditions [190]. The gene discussed is LAG3; the disease is cancer.